| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/11/2009 | US20090149383 Compositions and methods for facilitating heme-iron export from cells |
| 06/11/2009 | US20090149382 Modulation of lipid rafts |
| 06/11/2009 | US20090149381 Methods of regulating angiogenesis through stabilization of PEDF |
| 06/11/2009 | US20090149380 Vasostatin as marrow protectant |
| 06/11/2009 | US20090149379 Novel use of cytokine inhibitors |
| 06/11/2009 | US20090149378 Glp-1 analogues |
| 06/11/2009 | US20090149377 METHODS FOR REGULATION OF p53 TRANSLATION AND FUNCTION |
| 06/11/2009 | US20090149375 Use of the mst protein for the treatment of a thromboembolic disorder |
| 06/11/2009 | US20090149374 Neuropeptides |
| 06/11/2009 | US20090149373 Use of survivin to treat kidney failure |
| 06/11/2009 | US20090149372 bone morphogenic proteins; transforming growth factors; fusion proteins; drug screening; cardiovascular disorders |
| 06/11/2009 | US20090149371 Treatment of neurological deficits in the striatum or substanta nigra pars compacta |
| 06/11/2009 | US20090149339 Methods of Identifying Modulators of Interaction Between PDZ Domain Proteins and PL Proteins |
| 06/11/2009 | US20090149331 Methods and compositions for polypeptide engineering |
| 06/11/2009 | US20090148936 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/11/2009 | US20090148924 Proteases and variants thereof |
| 06/11/2009 | US20090148921 Compositions and methods for enhancing apoptosis |
| 06/11/2009 | US20090148900 Hemcm42 nucleic acids |
| 06/11/2009 | US20090148888 Recombinant toxin fragments |
| 06/11/2009 | US20090148884 Lat1 transporters expressed in blood brain barrier cells |
| 06/11/2009 | US20090148854 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 06/11/2009 | US20090148539 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090148507 Chimeric polypeptides containing chemokine domains |
| 06/11/2009 | US20090148505 Novel Antiproliferative Factor and Methods of Use |
| 06/11/2009 | US20090148502 Compositions and methods for treating lacerations, abrasions, avulsions, burns, ulcers, and cases of excessive bleeding |
| 06/11/2009 | US20090148495 Optimum Density Fibrous Matrix |
| 06/11/2009 | US20090148488 Bioactive coating for medical devices |
| 06/11/2009 | US20090148487 Moldable biomaterial for bone regeneration |
| 06/11/2009 | US20090148471 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 06/11/2009 | US20090148469 Multicomponent meningococcal vaccine |
| 06/11/2009 | US20090148468 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 06/11/2009 | US20090148466 Process for the Preparation of Hypoallergenic Mosaic Antigens |
| 06/11/2009 | US20090148465 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 06/11/2009 | US20090148462 Methods and compositions for use in treatment of patients with autoantibody positive disease |
| 06/11/2009 | US20090148460 Exosome ligands, their preparation and uses |
| 06/11/2009 | US20090148459 Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents |
| 06/11/2009 | US20090148458 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 06/11/2009 | US20090148457 Hepatocyte growth factor receptor antagonists and uses thereof |
| 06/11/2009 | US20090148456 Canine rankl and methods for preparing and using the same |
| 06/11/2009 | US20090148454 Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148448 Methods and compositions for modulating and detecting wisp activity |
| 06/11/2009 | US20090148446 Method and Composition for Treatment of Renal Failure with Antibodies and Their Equivalents as Partial or Complete Replacement for Dialysis |
| 06/11/2009 | US20090148444 Pharmaceutical composition for treating immune diseases |
| 06/11/2009 | US20090148442 COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE |
| 06/11/2009 | US20090148438 Binding Moieties Based on Shark Ignar Domains |
| 06/11/2009 | US20090148433 Metallo-protein and tocotrienol (mp-t3) compositions and uses thereof |
| 06/11/2009 | US20090148432 applying an antiproliferative agent capable of removing sialic acid residues, such as trans-sialidase, neuraminidase with plant extracts comprising nucleic acid-containing particles from garlic, ginkgo, tomato, orchid, guava, ginseng, ginger, and tobacco; anticholesterol agent |
| 06/11/2009 | US20090148431 Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cells |
| 06/11/2009 | US20090148430 Human obesity susceptibilty gene encoding potassium ion channels and uses thereof |
| 06/11/2009 | US20090148429 Debriding composition from bromelain and methods of production thereof |
| 06/11/2009 | US20090148428 treatment and search for diagnostic marker of hepatocellular carcinoma (HCC), glycogen storage disease, liver dysplasia, fatty liver and other liver disease |
| 06/11/2009 | US20090148427 Platelet glycoprotein ib alpha fusion polypeptides and methods of use thereof |
| 06/11/2009 | US20090148426 Composition for life extension and method of extending the life |
| 06/11/2009 | US20090148408 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 06/11/2009 | US20090148407 Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication |
| 06/11/2009 | US20090148406 Stable Aqueous Systems Comprising Proteins |
| 06/11/2009 | US20090148405 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf) receptor ligands |
| 06/11/2009 | US20090148404 Compositions and methods for eliminating undesired subpopulations of t cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
| 06/11/2009 | US20090148403 Interleukin-9 Antagonist Muteins and Their Pharmacological Methods of Use |
| 06/11/2009 | US20090148402 Therapy of non-malignant diseases or disorders with anti-erbb2 antibodies |
| 06/11/2009 | US20090148401 Methods and compositions for needleless delivery of binding partners |
| 06/11/2009 | US20090148400 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 06/11/2009 | US20090148389 Induction of mucosal tolerance to antigens |
| 06/11/2009 | US20090145432 Medicament delivery assembly |
| 06/11/2009 | EP1613724A2 Cell lines and host nucleic acid sequences related to infectious disease |
| 06/11/2009 | CA2708062A1 Radical therapeutic agent for keloid and hypertrophic scar |
| 06/11/2009 | CA2708050A1 Method for expanding hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | CA2708030A1 Composition |
| 06/11/2009 | CA2707666A1 Systems and methods for delivery of materials |
| 06/11/2009 | CA2707658A1 Protease variants for pharmaceutical use |
| 06/11/2009 | CA2707549A1 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism |
| 06/11/2009 | CA2707483A1 Protein formulations and methods of making same |
| 06/11/2009 | CA2706933A1 Nanoparticles of therapeutic agents having low water solubility |
| 06/11/2009 | CA2705986A1 Pharmaceutical preparation for treating benign prostatic hyperplasia |
| 06/11/2009 | CA2705780A1 Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink |
| 06/11/2009 | CA2702940A1 New non-selective somatostatin analogues |
| 06/10/2009 | EP2067863A2 Methods and compositions for diseases associated with amyloidosis |
| 06/10/2009 | EP2067862A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/10/2009 | EP2067790A2 Agonist antibody against protein tyrosine kinase SAL-S1 |
| 06/10/2009 | EP2067786A1 Novel non selective analogs of somatostatin |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067486A1 Use of CD23 antagonists for the treatment of neoplastic disorders |
| 06/10/2009 | EP2067484A2 Method for producing insulin in the form of an oral preparation |
| 06/10/2009 | EP2067483A1 Analogues of GLP-1 |
| 06/10/2009 | EP2067482A1 Agent for preventing development of reflex sympathetic dystrophy after stroke |
| 06/10/2009 | EP2067481A1 Therapeutic use of desacyl ghrelin |
| 06/10/2009 | EP2067480A1 Musclin receptor and use thereof |
| 06/10/2009 | EP2067042A2 Means and methods for diagnosing and/or treating a subject at risk of developing heart failure |
| 06/10/2009 | EP2067040A2 Use of at least one isoform of progesterone receptor membrane component 1 (pgrmc1) |
| 06/10/2009 | EP2066338A2 Use of growth hormone secretagogues to block or inhibit the renin-angiotensin system |
| 06/10/2009 | EP2066337A2 Use of exendins, exendin agonists and glp-1 receptor agonists for altering the concentration of fibrinogen |
| 06/10/2009 | EP2066336A2 Use of pegylated il-10 to treat cancer |
| 06/10/2009 | EP2066335A1 Cytokine signaling |
| 06/10/2009 | EP2066334A1 Rnai methods and compositions for stimulating proliferation of cells with adherent junctions |
| 06/10/2009 | EP2066328A2 Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors |
| 06/10/2009 | EP2066327A2 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
| 06/10/2009 | EP2066174A2 Compositions containing alpha-1-antitrypsin and methods for use |
| 06/10/2009 | EP2019587A4 Detection of protease and protease activity using a single nanocrescent sers probe |
| 06/10/2009 | EP1945783A4 Modulation of il-2 production by t-bet |